AstraZeneca Hits $2.45bn Q2 Profit as U.S. Sales Soar Amid Planned $50bn Investment
British pharmaceutical giant, AstraZeneca has reported a 27% rise in second-quarter net profit, reaching $2.45 billion, bolstered by record revenue growth in its key U.S. market. According to the company’s earnings statement released Tuesday, revenue surged 12% year-on-year to a quarterly record of $14.5 billion, driven largely by strong sales in its oncology portfolio. […]












